Cargando…

Pro-inflammation NF-κB signaling triggers a positive feedback via enhancing cholesterol accumulation in liver cancer cells

BACKGROUND: Hepatocellular carcinoma (HCC) develops in a complex microenvironment characterized by chronic inflammation. In recent years, cholesterol metabolic abnormalities have been implicated the importance in cancer cell physiology. This study was designed to investigate the relationship between...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Mingyan, Zhang, Wenhui, Dong, Yinying, Wang, Lishun, Fang, Tingting, Tang, Wenqing, Lv, Bei, Chen, Guanglang, Yang, Biwei, Huang, Peixin, Xia, Jinglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242086/
https://www.ncbi.nlm.nih.gov/pubmed/28100270
http://dx.doi.org/10.1186/s13046-017-0490-8
_version_ 1782496298199416832
author He, Mingyan
Zhang, Wenhui
Dong, Yinying
Wang, Lishun
Fang, Tingting
Tang, Wenqing
Lv, Bei
Chen, Guanglang
Yang, Biwei
Huang, Peixin
Xia, Jinglin
author_facet He, Mingyan
Zhang, Wenhui
Dong, Yinying
Wang, Lishun
Fang, Tingting
Tang, Wenqing
Lv, Bei
Chen, Guanglang
Yang, Biwei
Huang, Peixin
Xia, Jinglin
author_sort He, Mingyan
collection PubMed
description BACKGROUND: Hepatocellular carcinoma (HCC) develops in a complex microenvironment characterized by chronic inflammation. In recent years, cholesterol metabolic abnormalities have been implicated the importance in cancer cell physiology. This study was designed to investigate the relationship between inflammation and cholesterol accumulation in HCC cells. METHODS: Human HCC cells HepG2 and Huh7 were cultured and stimulated with lipopolysaccharide (LPS) for 24 h. The changes of HCC cells related to cholesterol metabolism including intracellular cholesterol concentrations, cholesterol uptake, and the expression of cholesterol-related genes 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), LDL receptor (LDLR), sterol regulatory element-binding transcription factor 2 (SREBF2), and proprotein convertase subtilisin/kexin 9 (PCSK9) were comparatively analyzed. Simultaneously, the effects of nuclear factor-kappa B (NF-κB) signaling pathway on cholesterol metabolism were clarified by knocking-down of nuclear factor kappa-B kinase subunit alpha (IKKα) and TGF-beta-activated kinase 1 and MAP3K7-binding protein 3 (TAB3) via RNAi and microRNA (miR)-195. Subsequently, the roles of cholesterol accumulation in LPS induced pro-inflammatory effects were further investigated. RESULTS: Pro-inflammatory factor LPS significantly increased intracellular cholesterol accumulation by upregulating the expression of HMGCR, LDLR, and SREBF2, while downregulating the expression of PCSK9. These effects were revealed to depend on NF-κB signaling pathway by knocking-down and overexpression of IKKα and TAB3. Additionally, miR-195, a regulator directly targeting IKKα and TAB3, blocked the effects of cholesterol accumulation, further supporting the critical role of pro-inflammation NF-κB signaling in regulating cholesterol accumulation. Intriguingly, the accumulation of cholesterol conversely exerted an augmented pro-inflammation effects by further activating NF-κB signaling pathway. CONCLUSIONS: These results indicated that pro-inflammation effects of NF-κB signaling could be augmented by a positive feedback via enhancing the cholesterol accumulation in liver cancer cells.
format Online
Article
Text
id pubmed-5242086
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52420862017-01-23 Pro-inflammation NF-κB signaling triggers a positive feedback via enhancing cholesterol accumulation in liver cancer cells He, Mingyan Zhang, Wenhui Dong, Yinying Wang, Lishun Fang, Tingting Tang, Wenqing Lv, Bei Chen, Guanglang Yang, Biwei Huang, Peixin Xia, Jinglin J Exp Clin Cancer Res Research BACKGROUND: Hepatocellular carcinoma (HCC) develops in a complex microenvironment characterized by chronic inflammation. In recent years, cholesterol metabolic abnormalities have been implicated the importance in cancer cell physiology. This study was designed to investigate the relationship between inflammation and cholesterol accumulation in HCC cells. METHODS: Human HCC cells HepG2 and Huh7 were cultured and stimulated with lipopolysaccharide (LPS) for 24 h. The changes of HCC cells related to cholesterol metabolism including intracellular cholesterol concentrations, cholesterol uptake, and the expression of cholesterol-related genes 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), LDL receptor (LDLR), sterol regulatory element-binding transcription factor 2 (SREBF2), and proprotein convertase subtilisin/kexin 9 (PCSK9) were comparatively analyzed. Simultaneously, the effects of nuclear factor-kappa B (NF-κB) signaling pathway on cholesterol metabolism were clarified by knocking-down of nuclear factor kappa-B kinase subunit alpha (IKKα) and TGF-beta-activated kinase 1 and MAP3K7-binding protein 3 (TAB3) via RNAi and microRNA (miR)-195. Subsequently, the roles of cholesterol accumulation in LPS induced pro-inflammatory effects were further investigated. RESULTS: Pro-inflammatory factor LPS significantly increased intracellular cholesterol accumulation by upregulating the expression of HMGCR, LDLR, and SREBF2, while downregulating the expression of PCSK9. These effects were revealed to depend on NF-κB signaling pathway by knocking-down and overexpression of IKKα and TAB3. Additionally, miR-195, a regulator directly targeting IKKα and TAB3, blocked the effects of cholesterol accumulation, further supporting the critical role of pro-inflammation NF-κB signaling in regulating cholesterol accumulation. Intriguingly, the accumulation of cholesterol conversely exerted an augmented pro-inflammation effects by further activating NF-κB signaling pathway. CONCLUSIONS: These results indicated that pro-inflammation effects of NF-κB signaling could be augmented by a positive feedback via enhancing the cholesterol accumulation in liver cancer cells. BioMed Central 2017-01-18 /pmc/articles/PMC5242086/ /pubmed/28100270 http://dx.doi.org/10.1186/s13046-017-0490-8 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
He, Mingyan
Zhang, Wenhui
Dong, Yinying
Wang, Lishun
Fang, Tingting
Tang, Wenqing
Lv, Bei
Chen, Guanglang
Yang, Biwei
Huang, Peixin
Xia, Jinglin
Pro-inflammation NF-κB signaling triggers a positive feedback via enhancing cholesterol accumulation in liver cancer cells
title Pro-inflammation NF-κB signaling triggers a positive feedback via enhancing cholesterol accumulation in liver cancer cells
title_full Pro-inflammation NF-κB signaling triggers a positive feedback via enhancing cholesterol accumulation in liver cancer cells
title_fullStr Pro-inflammation NF-κB signaling triggers a positive feedback via enhancing cholesterol accumulation in liver cancer cells
title_full_unstemmed Pro-inflammation NF-κB signaling triggers a positive feedback via enhancing cholesterol accumulation in liver cancer cells
title_short Pro-inflammation NF-κB signaling triggers a positive feedback via enhancing cholesterol accumulation in liver cancer cells
title_sort pro-inflammation nf-κb signaling triggers a positive feedback via enhancing cholesterol accumulation in liver cancer cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242086/
https://www.ncbi.nlm.nih.gov/pubmed/28100270
http://dx.doi.org/10.1186/s13046-017-0490-8
work_keys_str_mv AT hemingyan proinflammationnfkbsignalingtriggersapositivefeedbackviaenhancingcholesterolaccumulationinlivercancercells
AT zhangwenhui proinflammationnfkbsignalingtriggersapositivefeedbackviaenhancingcholesterolaccumulationinlivercancercells
AT dongyinying proinflammationnfkbsignalingtriggersapositivefeedbackviaenhancingcholesterolaccumulationinlivercancercells
AT wanglishun proinflammationnfkbsignalingtriggersapositivefeedbackviaenhancingcholesterolaccumulationinlivercancercells
AT fangtingting proinflammationnfkbsignalingtriggersapositivefeedbackviaenhancingcholesterolaccumulationinlivercancercells
AT tangwenqing proinflammationnfkbsignalingtriggersapositivefeedbackviaenhancingcholesterolaccumulationinlivercancercells
AT lvbei proinflammationnfkbsignalingtriggersapositivefeedbackviaenhancingcholesterolaccumulationinlivercancercells
AT chenguanglang proinflammationnfkbsignalingtriggersapositivefeedbackviaenhancingcholesterolaccumulationinlivercancercells
AT yangbiwei proinflammationnfkbsignalingtriggersapositivefeedbackviaenhancingcholesterolaccumulationinlivercancercells
AT huangpeixin proinflammationnfkbsignalingtriggersapositivefeedbackviaenhancingcholesterolaccumulationinlivercancercells
AT xiajinglin proinflammationnfkbsignalingtriggersapositivefeedbackviaenhancingcholesterolaccumulationinlivercancercells